Suppr超能文献

一名重症新型冠状病毒肺炎感染患者的类白血病反应

Leukemoid Reaction in a Patient With Severe COVID-19 Infection.

作者信息

Tarekegn Kidist, Colon Ramos Ana, Sequeira Gross Harry G, Yu Ming, Fulger Ilmana

机构信息

Internal Medicine, St. Barnabas Hospital Health System, The Bronx, USA.

Hematology-Oncology, St. Barnabas Hospital Health System, The Bronx, USA.

出版信息

Cureus. 2021 Feb 27;13(2):e13598. doi: 10.7759/cureus.13598.

Abstract

Leukemoid reaction is a rare clinical condition defined by marked leukocytosis with predominantly mature neutrophils. It is an uncommon condition with reported incidence of less than 1% in hospitalized patients. The major causes of leukemoid reaction are severe infection (clostridium difficile colitis, tuberculosis, or severe shigellosis), malignancies, intoxication, and severe hemorrhage. This article presents a case report of a 64-year-old female with severe COVID-19 infection who presented with marked leukocytosis. After extensive workup to exclude hematologic malignancy, the patient was diagnosed to have a leukemoid reaction.

摘要

类白血病反应是一种罕见的临床病症,其定义为以成熟中性粒细胞为主的显著白细胞增多。这是一种不常见的病症,据报道在住院患者中的发病率低于1%。类白血病反应的主要病因包括严重感染(艰难梭菌结肠炎、结核病或严重志贺菌病)、恶性肿瘤、中毒和严重出血。本文报告了一例64岁女性严重新型冠状病毒肺炎感染患者出现显著白细胞增多的病例。在进行广泛检查以排除血液系统恶性肿瘤后,该患者被诊断为类白血病反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8074/8011462/2477a09e1822/cureus-0013-00000013598-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验